These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 25032860)

  • 1. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27.
    Yalcin A; Clem BF; Imbert-Fernandez Y; Ozcan SC; Peker S; O'Neal J; Klarer AC; Clem AL; Telang S; Chesney J
    Cell Death Dis; 2014 Jul; 5(7):e1337. PubMed ID: 25032860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases.
    Yalcin A; Clem BF; Simmons A; Lane A; Nelson K; Clem AL; Brock E; Siow D; Wattenberg B; Telang S; Chesney J
    J Biol Chem; 2009 Sep; 284(36):24223-32. PubMed ID: 19473963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase Suppresses Neuronal Apoptosis by Increasing Glycolysis and "cyclin-dependent kinase 1-Mediated Phosphorylation of p27 After Traumatic Spinal Cord Injury in Rats.
    Gao L; Wang C; Qin B; Li T; Xu W; Lenahan C; Ying G; Li J; Zhao T; Zhu Y; Chen G
    Cell Transplant; 2020; 29():963689720950226. PubMed ID: 32841050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
    Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
    J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
    Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
    Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
    Imbert-Fernandez Y; Clem BF; O'Neal J; Kerr DA; Spaulding R; Lanceta L; Clem AL; Telang S; Chesney J
    J Biol Chem; 2014 Mar; 289(13):9440-8. PubMed ID: 24515104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation.
    Atsumi T; Nishio T; Niwa H; Takeuchi J; Bando H; Shimizu C; Yoshioka N; Bucala R; Koike T
    Diabetes; 2005 Dec; 54(12):3349-57. PubMed ID: 16306349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.
    Chesney J; Clark J; Klarer AC; Imbert-Fernandez Y; Lane AN; Telang S
    Oncotarget; 2014 Aug; 5(16):6670-86. PubMed ID: 25115398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
    Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
    Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase.
    Telang S; Yalcin A; Clem AL; Bucala R; Lane AN; Eaton JW; Chesney J
    Oncogene; 2006 Nov; 25(55):7225-34. PubMed ID: 16715124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.
    Yalcin A; Telang S; Clem B; Chesney J
    Exp Mol Pathol; 2009 Jun; 86(3):174-9. PubMed ID: 19454274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PFKFB2 regulates glycolysis and proliferation in pancreatic cancer cells.
    Ozcan SC; Sarioglu A; Altunok TH; Akkoc A; Guzel S; Guler S; Imbert-Fernandez Y; Muchut RJ; Iglesias AA; Gurpinar Y; Clem AL; Chesney JA; Yalcin A
    Mol Cell Biochem; 2020 Jul; 470(1-2):115-129. PubMed ID: 32415418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PFKFB3 is involved in breast cancer proliferation, migration, invasion and angiogenesis.
    Peng F; Li Q; Sun JY; Luo Y; Chen M; Bao Y
    Int J Oncol; 2018 Mar; 52(3):945-954. PubMed ID: 29393396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuances of PFKFB3 Signaling in Breast Cancer.
    Galindo CM; Oliveira Ganzella FA; Klassen G; Souza Ramos EA; Acco A
    Clin Breast Cancer; 2022 Jun; 22(4):e604-e614. PubMed ID: 35135735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sonic hedgehog stimulates glycolysis and proliferation of breast cancer cells: Modulation of PFKFB3 activation.
    Ge X; Lyu P; Gu Y; Li L; Li J; Wang Y; Zhang L; Fu C; Cao Z
    Biochem Biophys Res Commun; 2015 Aug; 464(3):862-8. PubMed ID: 26171876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Akt/PKB and PFKFB isoenzymes in the control of glycolysis, cell proliferation and protein synthesis in mitogen-stimulated thymocytes.
    Houddane A; Bultot L; Novellasdemunt L; Johanns M; Gueuning MA; Vertommen D; Coulie PG; Bartrons R; Hue L; Rider MH
    Cell Signal; 2017 Jun; 34():23-37. PubMed ID: 28235572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc stimulates cell cycle progression through the activation of Cdk1 and phosphorylation of p27.
    García-Gutiérrez L; Bretones G; Molina E; Arechaga I; Symonds C; Acosta JC; Blanco R; Fernández A; Alonso L; Sicinski P; Barbacid M; Santamaría D; León J
    Sci Rep; 2019 Dec; 9(1):18693. PubMed ID: 31822694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.
    Yi M; Ban Y; Tan Y; Xiong W; Li G; Xiang B
    Mol Metab; 2019 Feb; 20():1-13. PubMed ID: 30553771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment against glucose-dependent cancers through metabolic PFKFB3 targeting of glycolytic flux.
    Jones BC; Pohlmann PR; Clarke R; Sengupta S
    Cancer Metastasis Rev; 2022 Jun; 41(2):447-458. PubMed ID: 35419769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.